Wolfgang Hiddemann - Concepedia

Author

Wolfgang Hiddemann

Ludwig-Maximilians-Universität München ORCID

Also Known As

A. Ganser, E. Dühmke, Hiddemann W., Hiddemann, W., Hiddemann, Wolfgang, Lindner, L.H., W Hiddemann, W. Hiddemann, WOLFGANG HIDDEMANN, Wolfgang Hiddemann

308

Publications

10.5K

Citations

H-Index

122

Concepts

All Affiliations

Ludwig-Maximilians-Universität München Heidelberg University University of Göttingen University of Münster Helmholtz Zentrum München

About

Wolfgang Hiddemann is an author at Ludwig-Maximilians-Universität München specializing in medicine, hematology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	42	4.8K
2	Health Sciences	10	10	3.1K
3	Engineering	3	3	137
4	Natural Sciences	2	2	43
5	Nursing	2	2	69

Wolfgang Hiddemann

Publications

9.8K

Citations

H-Index

Page 1

	Year	Citations
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Bruce D. Cheson, John M. Bennett, Thomas Büchner, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaPathologyAcute LeukemiaResponse CriteriaHematological Malignancy	2003	2.6K
Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86 Alfred Reiter, Martin Schrappe, WD Ludwig, Blood	1994	614
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Martin Schrappe, Alfred Reiter, Wolfgang Ludwig, PubMed	2000	609
Improved outcome in adult B-cell acute lymphoblastic leukemia D. Hoelzer, WD Ludwig, E. Thiel, Blood	1996	316
Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML Sascha Haubner, Fabiana Perna, Thomas Köhnke, Leukemia	2018	311
Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia Sarah Ebinger, Erbey Ziya Özdemir, Christoph Ziegenhain, Cancer Cell	2016	277
Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles Claudia Schoch, Alexander Kohlmann, Susanne Schnittger, Proceedings of the National Academy of Sciences	2002	271
Heterozygous PU.1 mutations are associated with acute myeloid leukemia Beatrice U. Mueller, Thomas Pabst, Motomi Osato, Blood	2002	239
Patients with <i>de novo</i> acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients Claudia Schoch, Torsten Haferlach, Detlef Haase, British Journal of Haematology	2001	178
Adults with Philadelphia chromosome–like acute lymphoblastic leukemia frequently have <i>IGH-CRLF2</i> and <i>JAK2</i> mutations, persistence of minimal residual disease and poor prognosis Tobias Herold, Stephanie Schneider, Klaus H. Metzeler, Haematologica Mixed-phenotype Acute LeukemiaGeneticsImmunologyPathologyMyeloid Neoplasia	2016	161

Page 1